# OpenAI-backed Red Queen Bio raises $36M for AI antibody drugs

Digest AI · Business & Funding · published 2026-09-28T05:45:00Z

Canonical: https://digestai.news/story/openai-backed-red-queen-bio-raises-36m-for-ai-antibody-drugs

## Summary

Red Queen Bio, a startup backed by OpenAI, has raised $36 million to develop antibody drugs using artificial intelligence. The company focuses on designing treatments for novel pathogens, with a specific emphasis on preparing for threats posed by AI-enabled bioweapons. 

The startup's approach involves using AI to anticipate and create defenses against pathogens that future AI systems might generate. This proactive strategy aims to stay ahead of potential biosecurity risks by developing medical countermeasures before such threats become widespread. 

The funding highlights a growing intersection between AI capabilities and biosecurity, where companies are leveraging machine learning not just for discovery, but for defensive biological applications. OpenAI's involvement signals industry interest in addressing the dual-use nature of advanced AI in biology.

## Key points

- Red Queen Bio raised $36 million in funding.
- The startup is backed by OpenAI.
- It uses AI to design antibody drugs against novel pathogens and AI-enabled bioweapons.

## Why it matters

This highlights the emerging field of AI-driven biosecurity, where private companies are developing defensive tools against potential AI-created biological threats, signaling a shift in how bioweapons risks are managed.

## Sources

1. [A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup with $36M raised to design antibody drugs against pathogens, including AI-enabled bioweapons](https://wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b?st=3hXhHo) (wsj.com, 2026-09-28)

## Cite

Digest AI, "OpenAI-backed Red Queen Bio raises $36M for AI antibody drugs", 28 September 2026, https://digestai.news/story/openai-backed-red-queen-bio-raises-36m-for-ai-antibody-drugs

---

Written by Digest AI's editorial model from the linked sources; the sources are the record. Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse
JSON: https://digestai.news/story/openai-backed-red-queen-bio-raises-36m-for-ai-antibody-drugs.json